Suppr超能文献

硝苯地平和维拉帕米对运动诱发型心绞痛患者左心室功能的影响。

The effects on left ventricular performance of nifedipine and verapamil in exercise-induced angina pectoris.

作者信息

Silke B, Verma S P, Nelson G I, Ahuja R C, Hussain M, Taylor S H

出版信息

Br J Clin Pharmacol. 1984 Jun;17(6):735-43. doi: 10.1111/j.1365-2125.1984.tb02411.x.

Abstract

The differences between slow calcium blocking agents with respect to effects on heart rate, myocardial contractility and atrioventricular conducting time are well described; the relevance of such differences to the treatment of patients with impaired left ventricular function due to coronary heart disease is uncertain. The haemodynamic effects of equivalent hypotensive doses of nifedipine and verapamil were therefore compared in 20 patients with severe angina pectoris associated with angiographically documented coronary artery disease. The plasma concentrations of nifedipine (mean 57 +/- 19; range 27-77 ng/ml) and verapamil (mean 147 +/- 14; range 117-260 ng/ml) at the time of the haemodynamic measurements were of an order usually associated with substantial pharmacodynamic activity. Sitting at rest nifedipine resulted in reduction in systemic arterial pressure (P less than 0.05) and vascular resistance (P less than 0.01); both the heart rate (P less than 0.01) and cardiac output (P less than 0.05) increased without any significant change in the left heart filling pressure. In contrast, verapamil, which similarly reduced systemic blood pressure (P less than 0.05) and vascular resistance (P less than 0.01), increased cardiac output (P less than 0.05) and left heart filling pressure (P less than 0.05) without any change in heart rate. During upright bicycle exercise both drugs attenuated the angina induced in all subjects during the control exercise period. Despite reductions in systemic blood pressure and vascular resistance the cardiac output was unaltered on either drug at the same workload as in the control assessment. The reduction in exercise blood pressure following nifedipine induced a reflex tachycardia; this was not present, despite the similar hypotensive action, after verapamil.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

关于慢钙阻滞剂对心率、心肌收缩力和房室传导时间的影响,已有详尽描述;但这些差异与冠心病所致左心室功能受损患者治疗的相关性尚不确定。因此,对20例伴有血管造影证实的冠状动脉疾病的严重心绞痛患者,比较了等效降压剂量硝苯地平和维拉帕米的血流动力学效应。血流动力学测量时,硝苯地平的血浆浓度(平均57±19;范围27 - 77纳克/毫升)和维拉帕米的血浆浓度(平均147±14;范围117 - 260纳克/毫升)处于通常与显著药效学活性相关的水平。静息坐位时,硝苯地平使体动脉压降低(P<0.05)和血管阻力降低(P<0.01);心率(P<0.01)和心输出量增加(P<0.05),而左心充盈压无显著变化。相比之下,维拉帕米同样降低体循环血压(P<0.05)和血管阻力(P<0.01),增加心输出量(P<0.05)和左心充盈压(P<0.05),心率无变化。在直立自行车运动期间,两种药物均减轻了所有受试者在对照运动期诱发的心绞痛。尽管体循环血压和血管阻力降低,但在与对照评估相同的工作量下,两种药物对心输出量均无影响。硝苯地平使运动血压降低后诱发反射性心动过速;尽管维拉帕米有类似的降压作用,但未出现这种情况。(摘要截选至250字)

相似文献

1
The effects on left ventricular performance of nifedipine and verapamil in exercise-induced angina pectoris.
Br J Clin Pharmacol. 1984 Jun;17(6):735-43. doi: 10.1111/j.1365-2125.1984.tb02411.x.
8
An exercise hemodynamic comparison of verapamil, diltiazem, and amlodipine in coronary artery disease.
Cardiovasc Drugs Ther. 1990 Apr;4(2):457-63. doi: 10.1007/BF01857754.
10
Haemodynamic and radionuclide effects of amlodipine in coronary artery disease.
Br J Clin Pharmacol. 1990 Apr;29(4):437-45. doi: 10.1111/j.1365-2125.1990.tb03662.x.

引用本文的文献

1
Verapamil: a review of its pharmacological properties and therapeutic use in coronary artery disease.
Drugs. 1996 May;51(5):792-819. doi: 10.2165/00003495-199651050-00007.
3
Nifedipine. Relationship between pharmacokinetics and pharmacodynamics.
Clin Pharmacokinet. 1987 Jan;12(1):12-29. doi: 10.2165/00003088-198712010-00002.
5
Effects of nicardipine on cardiac volume at rest and during exercise-induced angina.
Br J Clin Pharmacol. 1985;20 Suppl 1(Suppl 1):169S-176S. doi: 10.1111/j.1365-2125.1985.tb05161.x.

本文引用的文献

1
Effects of nifedipine on resistance vessels, arteries and veins in man.
Br J Clin Pharmacol. 1980 Nov;10(5):433-8. doi: 10.1111/j.1365-2125.1980.tb01784.x.
2
Identification of nifedipine metabolites and their determination by gas chromatography.
Chem Pharm Bull (Tokyo). 1980 Jan;28(1):1-7. doi: 10.1248/cpb.28.1.
4
Pharmacokinetics of verapamil: experience with a sustained intravenous infusion regimen.
Am J Cardiol. 1982 Oct;50(4):716-21. doi: 10.1016/0002-9149(82)91224-3.
5
Hemodynamic and electrophysiologic effects of verapamil and nifedipine in patients on propranolol.
Am J Cardiol. 1982 Oct;50(4):704-710. doi: 10.1016/0002-9149(82)91222-x.
7
Hemodynamic consequences of combined beta-adrenergic and slow calcium channel blockade in man.
Circulation. 1982 Apr;65(4):660-8. doi: 10.1161/01.cir.65.4.660.
8
Combined therapy with verapamil and propranolol in chronic stable angina.
Am J Cardiol. 1982 Jan;49(1):125-32. doi: 10.1016/0002-9149(82)90286-7.
9
Calcium antagonist drugs in chronic stable angina. Comparison of verapamil and nifedipine.
Br Heart J. 1981 Nov;46(5):508-12. doi: 10.1136/hrt.46.5.508.
10
The combination of nifedipine and propranolol in the management of patients with angina pectoris.
Br J Clin Pharmacol. 1981 Aug;12(2):229-33. doi: 10.1111/j.1365-2125.1981.tb01205.x.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验